Clinical significance of serum CA-125, CA19-9 and CEA in pulmonary tuberculosis with and without type 2 diabetes

Tuberculosis (TB) has existed for millennia and remains a major global health problem. In 2015, TB led to approximately 1.4 million deaths [1]. China has the world's third largest TB epidemic, with more than 1.3 million new cases of TB every year [2]. As a consequence of its rapid economic development, aging, changed lifestyles and urbanization, China has also witnessed an escalating epidemic of diabetes mellitus (DM) [3]. DM is a well-known risk factors for the development of pulmonary TB (PTB).
Source: Tuberculosis - Category: Respiratory Medicine Authors: Source Type: research